3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Classical hematology
1
Conditions
Venous Thrombosis
1
Venous Thromboembolism
1
Thromboembolism
1
Pulmonary Embolism
1
Pancreatic Neoplasms
1
Interventions
apixaban
5
Dalteparin
5
edoxaban
2
bemiparin
2
abelacimab
2
Tinzaparin
2
Nadroparin
2
MAA868
2
Heparin, Low-Molecular-Weight
2
Enoxaparin
2
reviparin
1
isoquercitrin
1
certoparin
1
atezolizumab
1
acarboxyprothrombin
1
Warfarin
1
Rivaroxaban
1
Phenprocoumon
1
Intermittent Pneumatic Compression Devices
1
Fondaparinux
1
Dabigatran
1
Bevacizumab
1
Acenocoumarol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Venous Thrombosis
×
isoquercitrin
×
Clear all
NCT06861088
2026-02-02
CATIQ P3
Quercis Pharma AG
Phase 3
Recruiting
480 enrolled